Inventor · disambiguated record
Jed Wiltzius
Also filed as: WILTZIUS JED · WILTZIUS JED J · WILTZIUS JED J W
19 granted patents·14 pending applications·60 citations·filing 2012–2024
92Inventor score
Top patents by PatentIndex Score
33 records- 0195US10626187B2Antigen binding molecules specific for an anti-CD19 scFvKITE PHARMA INC·Filed 2017·Granted Apr 21, 2020·8 cites·12 claims
- 0295US10603380B2Chimeric antigen and T cell receptors and methods of useKITE PHARMA INC·Filed 2017·Granted Mar 31, 2020·16 cites·27 claims
- 0393US10844120B2Humanized antigen-binding domains and methods of useKITE PHARMA INC·Filed 2018·Granted Nov 24, 2020·8 cites·15 claims
- 0492US10844371B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2018·Granted Nov 24, 2020·6 cites·9 claims
- 0590US11572388B2Chimeric polypeptides and uses thereofKITE PHARMA INC·Filed 2020·Granted Feb 7, 2023·2 cites·7 claims
- 0690US11384155B2Antigen binding molecules specific for an anti-CD19 scFvKITE PHARMA INC·Filed 2020·Granted Jul 12, 2022·2 cites·12 claims
- 0788US2025243295A1Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 0886US10597456B2Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Mar 24, 2020·6 cites·46 claims
- 0985US11834654B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2020·Granted Dec 5, 2023·1 cites·5 claims
- 1084US10501775B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Dec 10, 2019·6 cites·20 claims
- 1183US11608517B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2019·Granted Mar 21, 2023·2 cites·15 claims
- 1281US12404305B2Chimeric polypeptides and uses thereofKITE PHARMA INC·Filed 2022·Granted Sep 2, 2025·0 cites·4 claims
- 1381US12202909B2Antigen binding molecules specific for an anti-CD19 scFVKITE PHARMA INC·Filed 2022·Granted Jan 21, 2025·0 cites·9 claims
- 1480US11390655B2Modified chimeric antigen receptors and methods of useKITE PHARMA INC·Filed 2018·Granted Jul 19, 2022·1 cites·6 claims
- 1579US10689450B2BCMA binding molecules and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Jun 23, 2020·1 cites·71 claims
- 1677US2024150750A1Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 1775US11793834B2Chimeric antigen and T cell receptors and methods of useKITE PHARMA INC·Filed 2019·Granted Oct 24, 2023·1 cites·17 claims
- 1874US2024115611A1Chimeric antigen and t cell receptors and methods of useKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 1973US12459979B2Modified chimeric antigen receptors and methods of useKITE PHARMA INC·Filed 2022·Granted Nov 4, 2025·0 cites·6 claims
- 2073US2023331855A1Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 2173US2023146195A1Bcma binding molecules and methods of use thereofKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 2271US11505613B2BCMA binding molecules and methods of use thereofKITE PHARMA INC·Filed 2019·Granted Nov 22, 2022·0 cites·22 claims
- 2366US2023124464A1Chimeric receptors to flt3 and methods of use thereofAMGEN INC·Filed 2022·Application pending·0 cites
- 2464US2020115457A1Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2019·Application pending·0 cites
- 2560US2019092818A1Chimeric polypeptides and uses thereofKITE PHARMA INC·Filed 2018·Application pending·0 cites
- 2660US2021061910A1Humanized Antigen-Binding Domains and Methods of UseKITE PHARMA INC·Filed 2020·Application pending·0 cites
- 2758US2020108142A1Chimeric antigen and t cell receptors and methods of useKITE PHARMA INC·Filed 2019·Application pending·0 cites
- 2853US2022396628A1Anti-idiotypic antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2020·Application pending·0 cites
- 2947US12012462B2Chimeric receptors to DLL3 and methods of use thereofAMGEN INC·Filed 2019·Granted Jun 18, 2024·0 cites·14 claims
- 3046US2018280437A1Chimeric antigen receptors for melanoma and uses thereofKITE PHARMA INC·Filed 2018·Application pending·0 cites
- 3145US2022160771A1Flt3-specific chimeric antigen receptors and methods of using the sameDIACONU IULIA·Filed 2020·Application pending·0 cites
- 3243US11820823B2T cell receptor antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2018·Granted Nov 21, 2023·0 cites·18 claims
- 3338US2014371427A1IgG2 DISULFIDE ISOFORM SEPARATIONAMGEN INC·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →